Valirx (VAL) RNS Announcements

Add to Alert list
Date Time Source Announcement
23 Jun 2011 07:00 AM
RNS
AGM Statement
21 Jun 2011 07:00 AM
RNS
GeneICE Update
10 Jun 2011 07:00 AM
RNS
Volition - update
02 Jun 2011 07:00 AM
RNS
Directorate Change
31 May 2011 01:30 PM
RNS
Publication of Report & Accounts and Notice of AGM
31 May 2011 07:00 AM
RNS
Final Results
31 May 2011 07:00 AM
RNS
Total Voting Rights
26 May 2011 02:56 PM
RNS
Holding(s) in Company
20 May 2011 07:00 AM
RNS
Website update
14 Apr 2011 07:00 AM
RNS
Agreements with Imperial College & Oxford Uni
04 Apr 2011 07:00 AM
RNS
Re Self-Test Health Report
24 Mar 2011 10:00 AM
RNS
SELFCheck Update
09 Mar 2011 02:54 PM
RNS
Holding(s) in Company
09 Mar 2011 11:15 AM
RNS
Holding(s) in Company
07 Mar 2011 10:56 AM
RNS
Result of EGM
07 Mar 2011 07:00 AM
RNS
Statement re General Meeting
25 Feb 2011 02:09 PM
RNS
Website Update
18 Feb 2011 02:54 PM
RNS
Publication of Circular and Notice of GM
16 Feb 2011 07:19 AM
RNS
Issue of Equity
14 Feb 2011 07:00 AM
RNS
Update
01 Feb 2011 11:38 AM
RNS
Total Voting Rights
31 Jan 2011 07:00 AM
RNS
Further re Sale of Belgian Su
27 Jan 2011 07:00 AM
RNS
Issue of Equity
26 Jan 2011 10:58 AM
RNS
Result of General Meeting
11 Jan 2011 07:00 AM
RNS
Publication of Circular and N
02 Dec 2010 07:00 AM
RNS
Update - Eurostars Programme
01 Dec 2010 07:00 AM
RNS
Total Voting Rights
10 Nov 2010 07:00 AM
RNS
Issue of equity and update
01 Nov 2010 04:12 PM
RNS
Total Voting Rights
29 Oct 2010 03:16 PM
RNS
Issue of Equity
29 Oct 2010 03:15 PM
RNS
Change of Adviser
11 Oct 2010 10:51 AM
RNS
Completion of Disposal
30 Sep 2010 02:17 PM
RNS
Half Yearly Report
23 Sep 2010 07:00 AM
RNS
Disposal
31 Aug 2010 07:00 AM
RNS
Total Voting Rights
16 Aug 2010 05:12 PM
RNS
Issue of Equity
12 Aug 2010 07:00 AM
RNS
Licensing Deal with Cancer Re
15 Jul 2010 07:00 AM
RNS
HPV Test Starts Clinical Vali
30 Jun 2010 10:15 AM
RNS
Result of AGM
17 Jun 2010 07:00 AM
RNS
Eurostars' GeneICE Programme
17 Jun 2010 07:00 AM
RNS
GeneICE Update
07 Jun 2010 07:00 AM
RNS
Final Results
24 May 2010 07:00 AM
RNS
Re Agreement
30 Apr 2010 02:47 PM
RNS
Total Voting Rights
21 Apr 2010 04:08 PM
RNS
Issue of Equity - Replacement
21 Apr 2010 03:14 PM
RNS
Result of General Meeting
01 Apr 2010 03:19 PM
RNS
Proposed reorg of share capit
01 Apr 2010 10:06 AM
RNS
Issue of Equity
01 Apr 2010 10:06 AM
RNS
Trading Update
31 Mar 2010 07:00 AM
RNS
Total Voting Rights

ValiRx PLC: A Biotech Innovator on the London Stock Exchange (LSE)

ValiRx PLC, known by its ticker symbol VAL, is a trailblazer in the biotechnology sector. Its performance on the London Stock Exchange (LSE) has been remarkable, with the ValiRx share price reflecting the company's consistent growth and success.

As a member of the LSE, ValiRx PLC aligns with the London Stock Exchange Group's (LSEG) mission of supporting innovative and growing businesses. The LSEG recognises ValiRx PLC as a significant player, contributing to the robust and diverse ecosystem of the LSE.

The ValiRx share price on the LSE not only underscores its financial stability but also its strategic vision in the biotechnology industry. ValiRx PLC's journey on the LSE is a testament to its robust business model and its ability to create value for its stakeholders.

In conclusion, ValiRx PLC's association with the LSE and LSEG symbolises its commitment to growth, innovation, and value creation. As ValiRx PLC continues to thrive on the LSE, it sets the bar high for the biotechnology industry, contributing to the dynamic and diverse ecosystem of the LSEG. With its focus on cancer therapeutics, ValiRx is a key player in the healthcare sector, making strides in medical research and development.

UK 100

Latest directors dealings